Nexalin Technology (NXL) Interest Coverage Ratio Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | 3,319.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,319.41% |
| Dec 31, 2025 | 862.23% |
| Sep 30, 2025 | -59.13% |
| Jun 30, 2025 | -98.24% |
| Mar 31, 2025 | -48.37% |
| Dec 31, 2024 | 1,959.38% |
| Sep 30, 2024 | 653.52% |
| Jun 30, 2024 | 12,466.72% |
| Mar 31, 2024 | 4,104.46% |
| Dec 31, 2023 | -59.09% |
| Sep 30, 2023 | -1,515.59% |
| Mar 31, 2023 | -326.33% |
| Dec 31, 2022 | -70.25% |
| Sep 30, 2022 | 57.54% |